Main Tel: 609-750-7330

Fax: 609-750-7336

COVID-19 Guidelines for Patient Visit > >

American Society of Hypertension Nationally Designated Hypertension Practice Center

Seema Basi, M.D., M.S.C.I., F.A.S.N.

Education:

High School: West Windsor Plainsboro South, Princeton Junction, NJ - National Merit Finalist

Undergraduate College: Northwestern University, Evanston, IL. Major in Molecular Biology

Medical School: Northwestern University Medical School, Chicago, IL

Internal Medicine Residency: Baylor College of Medicine Medical Center, Houston, TX

Nephrology Fellowship: Vanderbilt University Medical Center, Nashville, TN

Masters of Science in Clinical Investigation: Vanderbilt University, Nashville, TN

Accreditations:

2017 - Designated as a Certified Hypertension Specialist by the American Hypertension Specialist Certification Program

2007 - Designated as a Specialist in Clinical Hypertension by the American Society of Hypertension

Board Certified in Internal Medicine and Nephrology

Academic Position:

Clinical Associate Professor, Rutgers-Robert Wood Johnson Medical School, Piscataway, NJ

Medical Directorships

Medical Director, DaVita Princeton Junction Dialysis

Medical Director, DaVita Monroe Dialysis

Honors and Awards:

Fellow of the American Society of Nephrology

2017 Patient-Centered Outcomes Research Institute (PCORI) Tier A Pipeline to Proposal Award

2017 Davita Core Value Award

2014 Volunteer Faculty Award - Rutgers-RWJMS

2006 & 2007 Excellence in Teaching Award, St.Peters University Hospital/Drexel University College of Medicine

2004 - NIH funded Clinical Research Scholar

2004 - NKF Postdoctoral Research fellowship Grant

2003 - Honorable Mention for Outstanding contribution to clinical research – Amgen Young Investigators Forum

2002 - Award for Excellence in Ambulatory Medicine, Baylor College of Medicine

Elected to Phi Beta Kappa as an undergraduate (junior year)

7 year Honors Program for combined BA/MD degree at Northwestern University

Research:

2017-2018 Improving the Provision of Mental Health Care for Patients with End Stage Renal Disease and their Caregivers

2009-2010 Collaborative Study Group Trial of Pyridorin in Overt Diabetic Nephropathy (Phase IIb)

2007-2010 Altitude Study: Examining Effect of Renin-inhibitor Aliskiren on Cardiovascular and Renal Outcomes (Phase IV)

2005-2008 The Effect of Sulodexide in Patients with Type 2 Diabetes and Microalbuminuria or Overt Diabetic Nephropathy (Collaborative Study Group) (Phase III)

Dr Basi's Selected Publications:

Basi S., Fesler P., Mimran A., Lewis JB. Microalbuminuria in Type 2 Diabetes and Hypertension: a Marker, Treatment Target, or Innocent Bystander? Diabetes Care. 2008 Feb;31 Suppl 2:S149-201.

Basi S., Lewis JB. Microalbuminuria as a Target to Improve Cardiovascular and Renal Outcomes in Diabetic Patients. Current Diabetes Reports. 2007 Dec;7(6):439-42.

Basi S., Lewis JB. Microalbuminuria as a Target to Improve Cardiovascular and Renal Outcomes. AM J Kidney Dis. 2006 Jun;47(6):927-46.

Basi S., Pupim LB., Simmons EM., Sezer MT., Shyr Y., Freedman S., Chertow GM., Mehta RL., Paganini E., Himmelfarb J., Ikizler TA. Insulin Resistance in Critically ill Patients with Acute Renal Failure. Am J Physiol Renal Physiol. 2005 Aug;289(2):F259-64. Epub 2005 Apr 19.

Basi S., Schulman G., Fogo AB Multiple Complications in Multiple Myeloma. Am J Kidney Dis. 2005 Mar;45(3):619-23.